Chuyu Jing

566 total citations
23 papers, 432 citations indexed

About

Chuyu Jing is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Chuyu Jing has authored 23 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Chuyu Jing's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Chuyu Jing is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers) and Cancer, Lipids, and Metabolism (4 papers). Chuyu Jing collaborates with scholars based in China, Ethiopia and India. Chuyu Jing's co-authors include Yong Yi, Shuang–Jian Qiu, Su-Su Zheng, Yi‐Peng Fu, Meixia Zhang, Wei Gan, Boheng Zhang, Jiajia Lin, Xin Xu and Jian Zhou and has published in prestigious journals such as Oncogene, Medicine and BMC Medicine.

In The Last Decade

Chuyu Jing

22 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuyu Jing China 13 212 145 138 107 89 23 432
Yongliang Sun China 13 121 0.6× 211 1.5× 108 0.8× 123 1.1× 139 1.6× 34 473
Koji Minami Japan 10 128 0.6× 108 0.7× 69 0.5× 107 1.0× 91 1.0× 38 378
Mauro Alessandro Scotti Italy 9 205 1.0× 126 0.9× 53 0.4× 113 1.1× 151 1.7× 29 444
Vito Longo Italy 12 284 1.3× 65 0.4× 94 0.7× 127 1.2× 82 0.9× 29 487
Chiara Spoto Italy 10 279 1.3× 85 0.6× 123 0.9× 131 1.2× 117 1.3× 13 584
Chengyou Du China 14 188 0.9× 194 1.3× 102 0.7× 121 1.1× 275 3.1× 44 538
Yoshihiro Tokuhisa Japan 14 303 1.4× 136 0.9× 183 1.3× 184 1.7× 95 1.1× 32 601
Kumiko Umemoto Japan 11 237 1.1× 110 0.8× 93 0.7× 51 0.5× 43 0.5× 44 381
Toshiro Ogura Japan 11 270 1.3× 108 0.7× 140 1.0× 206 1.9× 94 1.1× 45 554
Pedro Luiz Serrano Usón Brazil 14 322 1.5× 181 1.2× 145 1.1× 102 1.0× 149 1.7× 59 584

Countries citing papers authored by Chuyu Jing

Since Specialization
Citations

This map shows the geographic impact of Chuyu Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuyu Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuyu Jing more than expected).

Fields of papers citing papers by Chuyu Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuyu Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuyu Jing. The network helps show where Chuyu Jing may publish in the future.

Co-authorship network of co-authors of Chuyu Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Chuyu Jing. A scholar is included among the top collaborators of Chuyu Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuyu Jing. Chuyu Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shen, Wenbin, Chuyu Jing, Wenjuan Tian, et al.. (2023). Anlotinib in patients with recurrent platinum resistant/refractory ovarian cancer: a prospective, single arm, phase II study. International Journal of Gynecological Cancer. 33(11). 1764–1770. 5 indexed citations
3.
Jing, Chuyu, Shengnan Li, Boer Shan, et al.. (2022). Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma. Clinical Medicine Insights Oncology. 16. 1363231482–1363231482. 7 indexed citations
4.
Jing, Chuyu, Yi‐Peng Fu, Cheng Zhou, et al.. (2021). Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis. Oncogene. 40(16). 2910–2922. 17 indexed citations
5.
Huang, Yan, Midie Xu, Chuyu Jing, et al.. (2021). Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer. Discover Oncology. 12(1). 7 indexed citations
6.
Zheng, Su-Su, Linxia Liu, Tong‐Chun Xue, et al.. (2021). Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma. Frontiers in Genetics. 12. 648156–648156. 17 indexed citations
7.
Jing, Chuyu, Yi‐Peng Fu, Yong Yi, et al.. (2019). HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1. Journal for ImmunoTherapy of Cancer. 7(1). 77–77. 91 indexed citations
8.
Zhang, Meixia, Wei Gan, Chuyu Jing, et al.. (2019). High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection. Journal of Cancer. 10(5). 1313–1324. 11 indexed citations
9.
Lin, Jiajia, Tingting Fang, Xin Xu, et al.. (2019). <p>Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma</p>. Cancer Management and Research. Volume 11. 9107–9119. 23 indexed citations
10.
Gan, Wei, Meixia Zhang, Jiaxing Wang, et al.. (2018). Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child&ndash;Pugh I who underwent curative resection: a prognostic nomogram study. Cancer Management and Research. Volume 10. 5383–5394. 20 indexed citations
11.
Gan, Wei, Meixia Zhang, Yi‐Peng Fu, et al.. (2018). New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection. Journal of Surgical Oncology. 117(7). 1540–1547. 36 indexed citations
12.
Zhang, Meixia, Wei Gan, Chuyu Jing, et al.. (2018). Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection. Cancer Science. 109(4). 1195–1206. 11 indexed citations
13.
Zhang, Meixia, Su-Su Zheng, Chuyu Jing, et al.. (2018). S100A11 Promotes TGF-β1 -Induced Epithelial–Mesenchymal Transition Through SMAD2/3 Signaling Pathway in Intrahepatic Cholangiocarcinoma. Future Oncology. 14(9). 837–847. 18 indexed citations
14.
Zheng, Su-Su, Rongxin Chen, Xuejuan Jin, et al.. (2017). Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Medicine. 96(28). e7438–e7438. 12 indexed citations
15.
Jing, Chuyu, Yi‐Peng Fu, Su-Su Zheng, et al.. (2017). Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine. 96(11). e6140–e6140. 6 indexed citations
16.
17.
18.
Fu, Yi‐Peng, Yong Yi, Jinlong Huang, et al.. (2017). Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. The Oncologist. 22(5). 561–569. 33 indexed citations
19.
Jiang, Liyu, Chuyu Jing, Xiaoli Kong, et al.. (2016). Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma. Oncology Letters. 12(2). 1448–1454. 2 indexed citations
20.
Jing, Chuyu, Yi‐Peng Fu, Su-Su Zheng, et al.. (2016). Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection. Oncotarget. 8(8). 13293–13303. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongliang Sun Breakdown of academic impact, for papers by Koji Minami Breakdown of academic impact, for papers by Mauro Alessandro Scotti Breakdown of academic impact, for papers by Vito Longo Breakdown of academic impact, for papers by Chiara Spoto Breakdown of academic impact, for papers by Chengyou Du Breakdown of academic impact, for papers by Yoshihiro Tokuhisa Breakdown of academic impact, for papers by Kumiko Umemoto Breakdown of academic impact, for papers by Toshiro Ogura Breakdown of academic impact, for papers by Pedro Luiz Serrano Usón
Rankless by CCL
2026